Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: Results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

British Journal of Dermatology

Volumn 166, Issue 1, 2012, Pages 137-146

  Dirschka, T ^a,z   Radny, P ^b   Dominicus, R ^c   Mensing, H ^d   Bruning H ^e   Jenne, L ^f   Karl, L ^g   Sebastian, M ^h   Oster Schmidt, C ⁱ   Klovekorn W ^h   Reinhold, U ^j   Tanner, M ^k   Grone D ^l   Deichmann, M ^h   Simon, M ^l   Hubinger F ^m   Hofbauer, G ⁿ   Krahn Senftleben G ^o   Borrosch, F ^p   Reich, K ^q   Berking, C ^r   Wolf, P ^s   Lehmann, P ^t   Moers Carpi, M ^u   Honigsmann H ^v   Wernicke Panten, K ^w   Helwig, C ^w   Foguet, M ^x   Schmitz, B ^x   Lubbert H ^x   Szeimies, R M ^y,aa   more..

^a Private Dermatological Practice Centre   (Germany)

^b Private Dermatological Practice   (Germany)

^c Private Practice Drs Joachim Bockhorst and Rolf Dominicus   (Germany)

^d Sellspeicher   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f Private Practice im Sellspeicher   (Germany)

^g Dermatological Practice   (Germany)

^h Private Practice ^*  (Germany)

ⁱ Private Practice for Skin and Genital Diseases Altenkirchen   (Germany)

^j Medical Centre Bonn   (Germany)

^k Private Practice   (Germany)

^l Dermatological Practice   (Germany)

^m Private Practice   (Germany)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o SANA KLINIKUM OFFENBACH   (Germany)

^p Focus Clinical Drug Development GmbH   (Germany)

^q SCIderm GmbH   (Germany)

^r UNIVERSITY OF MUNICH   (Germany)

^s MEDICAL UNIVERSITY OF GRAZ   (Austria)

^t HELIOS KLINIKUM WUPPERTAL   (Germany)

^u Private Practice for Skin Diseases Operative and Aesthetic Dermatology   (Germany)

^v University Hospital for Dermatology   (Austria)

^w ACCOVION GMBH   (Germany)

^x Biofrontera Pharmaceuticals GmbH   (Germany)

^y UNIVERSITY OF REGENSBURG   (Germany)

^z UNIVERSITY OF WITTEN HERDECKE   (Germany)

^aa Klinikum Vest   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; BF 200 5 AMINOLAEVULINIC ACID; PHOTOSENSITIZING AGENT; PLACEBO; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; APPLICATION SITE BURNING; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE EXFOLIATION; APPLICATION SITE INDURATION; APPLICATION SITE PAIN; APPLICATION SITE PARESTHESIA; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; APPLICATION SITE SCABBING; APPLICATION SITE VESICLE; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FACE; FEMALE; HUMAN; LIGHT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP; SINGLE BLIND PROCEDURE; SKIN DISCOMFORT; SKIN MANIFESTATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FEMALE; GELS; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84555212538     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10613.x     Document Type: Article

References (25)

1. Frost CA, Green AC, Williams GM,. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol 1998; 139: 1033-9. (Pubitemid 29010541)
2. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 2007; 56: 125-43. (Pubitemid 44969292)
3. Rowert-Huber J, Patel MJ, Forschner T, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007; 156 (Suppl. 3): 8-12. (Pubitemid 46632512)
4. Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic keratosis'). J Am Acad Dermatol 2000; 42: 11-17.
5. Babilas P, Karrer S, Sidoroff A, et al. Photodynamic therapy in dermatology-an update. Photodermatol Photoimmunol Photomed 2005; 21: 142-9. (Pubitemid 40778615)
6. Glogau RG,. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23-4.
7. Stockfleth E, Kerl H,. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16: 599-606.
8. de Berker D, McGregor JM, Hughes BR,. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-30. (Pubitemid 46098882)
9. Juzeniene A, Moan J,. The principles of 5-aminolevulinic acid photodynamic therapy. In: Photodynamic Therapy at the Cellular Level (, Uzdensky AB, ed.). Trivandrum: Research Signpost, 2007; 115-40.
10. Maisch T, Santarelli F, Schreml S, et al. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp Dermatol 2010; 19: e302-5.
11. Szeimies RM, Radny P, Sebastian M, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Br J Dermatol 2010; 163: 386-94.
12. Galderma. Summary of Product Characteristics, Metvix. Watford: Galderma, 2008.
13. Olsen EA, Abernethy ML, Kulp-Shorten C, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-43.
14. Kasche A, Luderschmidt S, Ring J, et al. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006; 5: 353-6.
15. Gaullier JM, Berg K, Peng Q, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 1997; 57: 1481-6. (Pubitemid 27175564)
16. Fink-Puches R, Hofer A, Smolle J, et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B 1997; 41: 145-51. (Pubitemid 28010589)
17. Tschen EH, Wong DS, Pariser DM, et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006; 155: 1262-9. (Pubitemid 44730005)
18. Pariser D, Loss R, Jarratt M, et al. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol 2008; 59: 569-76.
19. Szeimies RM, Matheson RT, Davis SA, et al. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study. Dermatol Surg 2009; 35: 586-92.
20. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62.
21. Hauschild A, Stockfleth E, Popp G, et al. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 2009; 160: 1066-74.
22. Dusa Pharmaceuticals. Summary of Product Characteristics, Levulan®Kerastick®, NDA20-965/S-006. Wilmington, MA: Dusa Pharmaceuticals, 2009.
23. Babilas P, Kohl E, Maisch T, et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 2006; 154: 712-18. (Pubitemid 43374097)
24. Moloney FJ, Collins P,. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007; 157: 87-91. (Pubitemid 46934264)
25. Karrer S, Baumler W, Abels C, et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999; 25: 51-9. (Pubitemid 29379091)